Order results by:
Issue | Title | |
Vol 12, No 4 (2016) | Morphometric changes of the left ventricle and characteristics of peripheral hemodynamics in patients with drug resistant hypertension | Abstract similar documents |
R. R. Kushkhova, A. G. Avtandilov | ||
"... .8 g/m vs 102.5±3.4 g/m² in Group 2 (p<0.05). The relative left ventricular wall thickness in Group 1 ..." | ||
Vol 12, No 2 (2016) | RESISTANT HYPERTENSION: THE AWARENESS OF DOCTORS AND THE EFFECTIVENESS OF THE COMBINATION THERAPY | Abstract similar documents |
R. R. Kushkhova, A. G. Avtandilov, A. A. Pukhaeva | ||
"... Aim. To study the doctor awareness of the criteria of resistant hypertension (RHT) and to evaluate ..." | ||
Vol 11, No 6 (2015) | Nephrogenic factors of resistance to antihypertensive treatment in patients with essential hypertension | Abstract similar documents |
N. V. Teplova, V. A. Lyusov, R. G. Oganov, E. M. Evsikov, R. A. Sharipov, M. H. Zhapoeva, E. G. Kurumlidu | ||
"... was performed. Results. A group of patients with resistant HT made 36.7% of the total number of examined ..." | ||
Vol 17, No 2 (2021) | Treatment of Resistant Hypertension in Real Clinical Settings | Abstract similar documents |
A. S. Maltseva, A. E. Tsygankova, M. A. Gabitova, A. V. Rodionov, V. V. Fomin | ||
"... with resistant hypertension, however, in real clinical settings the number of non-rational and ineffective ..." | ||
Vol 12, No 3 (2016) | CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE RESISTANT TO ACETYLSALICYLIC ACID IN PERIOPERATIVE PERIOD OF CORONARY ARTERY BYPASS GRAFT: RESULTS OF AN OPEN PROSPECTIVE STUDY | Abstract PDF (Eng) similar documents |
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein, A. V. Kovalev, V. G. Sukhovol'skiy, A. A. Savchenko | ||
"... characteristics of blood and platelets were found in the groups of ASA-resistant and ASA-sensitive patients 10 ..." | ||
Vol 20, No 4 (2024) | Baxdrostat and finerenone: new aldosterone synthase-aldosterone-mineralocorticoid receptor hormonal system inhibitors for the drug treatment of resistant arterial hypertension | Abstract similar documents |
O. B. Kuzmin, N. V. Buchneva, V. V. Belyanin, V. V. Zhezha, M. V. Stolbova | ||
"... , including diuretic. Patients with resistant hypertension are included in a group of people at high risk ..." | ||
Vol 11, No 3 (2015) | RENAL DENERVATION IN THE TREATMENT OF RESISTANT HYPERTENSION: RESULTS OF A ONE-YEAR OBSERVATIONAL STUDY | Abstract similar documents |
V. A. Sulimov, A. V. Rodionov, A. A. Svetankova | ||
"... and vegetative status in patients with resistant hypertension (HT). Material and methods. Patients ..." | ||
Vol 9, No 3 (2013) | RENAL DENERVATION IN RESISTANT ARTERIAL HYPERTENSION | Abstract similar documents |
V. A. Sulimov, A. V. Rodionov, A. A. Svetankova, I. E. Deneka | ||
"... A new method of non-drug treatment of resistant hypertension – renal denervation is considered ..." | ||
Vol 11, No 2 (2015) | RESISTANT ARTERIAL HYPERTENSION: IS THE CONSENSUS BETWEEN CONSERVATIVE AND INTERVENTIONAL THERAPY POSSIBLE? | Abstract similar documents |
Yu. I. Grinshtein, V. V. Shabalin | ||
"... Resistant hypertension is defined as hypertension uncontrolled with optimal doses of three ..." | ||
Vol 12, No 4 (2016) | Resistant hypertension: epidemiology and risk factors | Abstract similar documents |
I. E. Deneka, A. A. Svetankova, A. V. Rodionov | ||
"... modifiable causes of resistant hypertension, that are often underestimated, are considered: obesity ..." | ||
Vol 15, No 4 (2019) | Resistant Hypertension: Questions and Contemporary Answers | Abstract similar documents |
V. I. Podzolkov, A. E. Bragina, K. K. Osadchiy | ||
"... The review presents the important problem of resistant hypertension. Its real prevalence ..." | ||
Vol 12, No 6 (2016) | RESISTANT HYPERTENSION IN A PATIENT WITH METABOLIC SYNDROME | Abstract similar documents |
O. M. Drapkina, J. S. Sibgatullina | ||
"... Clinical case of resistant hypertension in a patient with metabolic syndrome is presented ..." | ||
Vol 19, No 4 (2023) | Paradigm shift on the role of mineralocorticoid receptor antagonists in hypertension therapy | Abstract similar documents |
S. R. Gilyarevsky, D. O. Ladygina | ||
"... (MRAs), in particular spironolactone, in the treatment of hyperaldosteronism and resistant hypertension ..." | ||
Vol 20, No 3 (2024) | Theory and practice of selective imidazoline receptor agonist use in Russia | Abstract similar documents |
N. I. Gaponova, V. R. Abdrakhmanov | ||
Vol 16, No 1 (2020) | Deprescribing Antihypertensive Drugs in Patients of Older Age Groups | Abstract similar documents |
O. D. Ostroumova, M. S. Cherniaeva, D. A. Sychev | ||
"... guidelines for the treatment of AH determine specific approaches for managing patients of older age groups ..." | ||
Vol 7, No 5 (2011) | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva | ||
"... placebo (5.6±2.1 and 4.3±1.4, respectively , vs 8.6±2.4 episodes per month; p<0.05), the need ..." | ||
Vol 6, No 6 (2010) | WORKING GROUP OF THE YOUNG CARDIOLOGISTS HAS BEEN ESTABLISHED AT THE SOCIETY OF CARDIOLOGY OF THE RUSSIAN FEDERATION | Abstract similar documents |
"... Working group of the Young Cardiologists has been established at the Society of Cardiology ..." | ||
Vol 12, No 5 (2016) | Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome | Abstract similar documents |
I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova | ||
"... in acetylsalicylic acid (ASA) sensitive and resistant patients with acute coronary syndrome (ACS). Material ..." | ||
Vol 12, No 3 (2016) | ESTIMATION OF RIGHT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE IN DIFFERENT AGE GROUPS | Abstract PDF (Eng) similar documents |
R. A. Gajfulin, A. N. Sumin, O. G. Arhipov | ||
"... with ischemic heart disease (IHD) in different age groups. Material and methods. Patients (n=678) with IHD aged ..." | ||
Vol 14, No 3 (2018) | THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS | Abstract similar documents |
O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova | ||
Vol 10, No 1 (2014) | ADHERENCE TO LONG-TERM TREATMENT OF CARDIOVASCULAR DISEASE AND NON-COMPLIANCE WITH MEDICAL RECOMMENDATIONS: THE OPINION OF PATIENTS AND PHYSICIANS BY THE RESULTS OF FOCUSED INTERVIEW | Abstract similar documents |
O. N. Semenova, E. A. Naumova, Yu. G. Schwartz | ||
"... with adherence to treatment for chronic cardiovascular diseases in the group focused interview of patients ..." | ||
Vol 8, No 1 (2012) | RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
V. A. Sulimov, E. V. Moroz | ||
"... to group A (n=53) received clopidogrel 75 mg daily for 7 days before PCI, and later were allocated ..." | ||
Vol 13, No 3 (2017) | SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION | Abstract similar documents |
S. B. Fitilev, D. A. Dimitrova, I. I. Shkrebneva, A. V. Vozzhaev | ||
"... groups with a history of myocardial infarction by the example of outpatient cardiology institution ..." | ||
Vol 5, No 3 (2009) | ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 | Abstract similar documents |
E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva | ||
"... patients were involved in the study and split into two groups. 100 patients (47 men, 53 women; aged 66,4±7 ..." | ||
Vol 18, No 3 (2022) | Study the Association of Nucleotide Polymorphisms in Platelet Receptor and Cytochrome P450 Genes with the Development of Resistance to Antiplatelet Drugs in Patients with Coronary Artery Disease | Abstract similar documents |
K. S. Semashchenko, T. S. Mongush, A. A. Kosinova, T. N. Subbotina, Y. I. Grinshtein | ||
"... P450 genes between the groups of aspirin-sensitive and aspirin-resistant patients, as well ..." | ||
Vol 8, No 4 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) | Abstract similar documents |
S. Y. Martsevich, S. N. Tolpygina | ||
"... groups. The patients were randomized into two groups: the group 1 (n=53) started treatment ..." | ||
Vol 8, No 5 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) | Abstract similar documents |
S. Y. Martsevich, S. N. Tolpigina | ||
"... into randomized, an open-label comparative stepped trial. The patients were randomized into two groups: the group ..." | ||
Vol 13, No 2 (2017) | ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE | Abstract similar documents |
V. I. Podzolkov, N. A. Dragomiretskaya | ||
"... , in treatment of such conditions as primary hyperaldosteronism, resistant hypertension, edematous syndrome ..." | ||
Vol 6, No 2 (2010) | REFRACTORY HYPERTENSION – MODERN APPROACHES TO DIAGNOSTICS AND TREATMENT | Abstract similar documents |
A. N. Britov, M. M. Bystrova | ||
"... Резистентную артериальную гипертонию (АГ) диагностируют, если при приеме трех антигипертензивных ..." | ||
Vol 12, No 5 (2016) | Arterial Hypertension in Patients with Rheumatoid Arthritis. What should be known and considered at diagnosis and treatment? | Abstract similar documents |
N. M. Nikitina, T. A. Romanova, I. A. Afanas'ev, M. A. Tyapkina, A. P. Rebrov | ||
"... patients with RA 7.5% of patients had resistant HT, 36.8% - do not regularly control BP. During daily ..." | ||
Vol 14, No 6 (2018) | Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2 | Abstract PDF (Eng) similar documents |
V. V. Skibitskiy, A. A. Kiselev, A. V. Fendrikova | ||
"... <0.05 in comparison with the group 1B). In the case of salt-resistant patients, there were comparable ..." | ||
Vol 5, No 6 (2009) | RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID | Abstract similar documents |
N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky | ||
"... ,6% among ASA sensitive patients and 50% - among ASA resistant patients. Repeated atherothrombotic events ..." | ||
Vol 4, No 2 (2008) | ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION | Abstract similar documents |
D. H. Ainetdinova, A. Е. Udovichenko, V. A. Sulimov | ||
"... aggregation after 7 days of the therapy compared to the basal levels (р<0,05). The highest incidence ..." | ||
Vol 19, No 5 (2023) | White coat effect in patients with hypertension | Abstract similar documents |
G. F. Andreeva, V. M. Gorbunov, D. N. Antipushina, E. V. Platonova | ||
"... , a large number of methods are used, which can be divided into following groups: I – data from clinical ..." | ||
Vol 15, No 4 (2019) | Atrial Septal Aneurysm in Adult Patients of Therapeutic Hospital | Abstract similar documents |
O. V. Ryazantseva, N. I. Lenkova, O. D. Ostroumova, E. V. Shikh, S. M. Rykova | ||
"... in patients of the older age group of the therapeutic hospital, as well as combinations with other structural ..." | ||
Vol 17, No 2 (2021) | Current Guidelines for the Treatment of Arterial Hypertension in Patients with Diabetes Mellitus and Chronic Kidney Disease | Abstract similar documents |
T. Yu. Demidova, O. A. Kislyak | ||
"... is that patients with DM and CKD represent a special group of patients with a very high risk of CVD ..." | ||
Vol 15, No 4 (2019) | Antimicrobial Treatment of Infective Endocarditis, Caused by Enterococcus Faecalis | Abstract PDF (Eng) similar documents |
E. V. Shikh, T. E. Morozova, V. N. Drozdov, N. B. Lazareva, D. A. Shatsky, T. B. Andrushchyshina, M. V. Lukina, O. A. Vartanova | ||
"... of new groups of antibacterial drugs. This review includes the results of studies of the efficacy ..." | ||
Vol 8, No 1 (2012) | CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 1 | Abstract similar documents |
V. V. Popov, N. A. Bulanov, G. G. Ivanov | ||
"... . Despite progress in treatment of this disease, a number of people with uncontrolled or resistant HT ..." | ||
Vol 8, No 2 (2012) | CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2 | Abstract similar documents |
V. V. Popov, N. A. Bulanov, G. G. Ivanov | ||
"... . Despite progress in treatment of this disease, a number of people with uncontrolled or resistant HT ..." | ||
Vol 9, No 1 (2013) | ASTHENIC DISORDERS IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION: MANAGEMENT POTENTIAL OF MELDONIUM | Abstract similar documents |
M. E. Statsenko, S. V. Nedogoda, S. V. Turkina, I. A. Tyshchenko, L. V. Poletaeva, V. V. Tsoma, A. A. Ledyaeva, E. V. Chumachok | ||
"... .7% (p<0.05), with reduced activity — on 33.3%, reduced motivation — on 25%. In group2 a number ..." | ||
Vol 18, No 3 (2022) | Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER | Abstract similar documents |
I. A. Zolotovskaya, V. P. Kuzmin, O. A. Rubanenko, P. R. Shatskaya, A. S. Salasyuk | ||
"... frequent use of angiotensin II receptor blockers in group 2, p<0.05), lipid profile and blood pressure ..." | ||
Vol 18, No 5 (2022) | Hepcidin as a Regulator of Iron Metabolism and Mediator of Inflammation in Patients with Chronic Heart Failure and Anemia of Chronic Diseases of the Elderly and Senile Age | Abstract similar documents |
N. I. Solomakhina, A. S. Lishuta, A. V. Dementieva | ||
"... with the ferrokinetic parameter – serum iron [r(S)=0.480, p<0.05] were found in the control group. Normal levels ..." | ||
Vol 11, No 5 (2015) | Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation | Abstract similar documents |
E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov | ||
"... (n=19; 57.6%) compared with the group TCZ+MTX (n=7; 18%), (p<0.05). The lipid levels correlated ..." | ||
Vol 17, No 1 (2021) | Aspirin Resistance as a Result of Impaired Interaction of Platelets and Neutrophils in Patients with Coronary Heart Disease | Abstract similar documents |
M. D. Goncharov, A. A. Savchenko, Yu. I. Grinshtein, I. I. Gvozdev, A. A. Kosinova, T. S. Mongush | ||
"... group consisted of 30 healthy donors. The antiplatelet therapy was stopped for at least 5 days before ..." | ||
Vol 8, No 4 (2012) | THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
L. E. Chekuldaeva, S. V. Obuhova, A. A. Simakov, L. V. Poljaeva, E. I. Rjazanova | ||
"... — by 61.8%, after 2 months — 72.5%, p<0.05) were found in the intervention group compared with the control ..." | ||
Vol 18, No 3 (2022) | Aromatic Amino Acids: Phenylalanine and Tyrosine in Patients with Hypertension and Coronary Artery Disease | Abstract similar documents |
A. V. Krivova, M. V. Kozhevnikova, E. O. Korobkova, V. Yu. Zektser, E. A. Zheleznykh, А. A. Ageev, N. E. Moskaleva, A. V. Kukharenko, S. A. Appolonova, Yu. N. Belenkov | ||
"... ,543, respectively, p<0,05), and the level of Tyr with LDL (r=0,349, p<0,05). When isolating the group with proven ..." | ||
Vol 6, No 4 (2010) | MODERN PHARMACOTHERAPY OF THE STABLE ANGINA: POSSIBILITIES AND PROSPECTS OF NICORANDIL IMPLEMENTATION | Abstract similar documents |
Z. M. Sizova, E. V. Shikh, V. L. Zakharova, E. V. Smirnova | ||
"... in 2 groups. Patients of the 1st group (n=15) received nicorandil 20 mg TID, patients of the 2nd group ..." | ||
Vol 8, No 1 (2012) | THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME | Abstract similar documents |
S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, V. P. Voronina, L. Yu. Drozdova | ||
"... , respectively (p>0.05). Target BP was achieved in 23 patients (77%) in both randomized groups. Serious adverse ..." | ||
Vol 11, No 5 (2015) | Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders | Abstract similar documents |
B. U. Mardanov, M. N. Mamedov, M. N. Korneeva, R. G. Oganov | ||
"... aneurysm 12% more often in patients of group 1 (p<0.05). The duration of inpatient treatment was also ..." | ||
Vol 14, No 3 (2018) | RELATION OF DISTURBANCES IN THE ERYTHROCYTES ELECTRICAL ACTIVITY WITH DYSLIPIDEMIA IN THE METABOLIC SYNDROME | Abstract similar documents |
V. I. Podzolkov, T. V. Koroleva, A. E. Bragina, M. G. Kudryavtseva, G. I. Bragina, M. V. Pisarev | ||
"... ×107) was lower than this in the control group (1.65±0.03×107; p<0.05). With MS duration more than 5 ..." | ||
Vol 5, No 1 (2009) | COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL | Abstract similar documents |
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina | ||
"... and HCT was made more often in M group than in C group (p>0,05). Prescription of BB resulted ..." | ||
Vol 14, No 2 (2018) | CHANGE IN THE FUNCTIONAL STATE OF ERYTHROCYTES AS A COMPONENT OF MICROCIRCULATORY DISORDERS IN METABOLIC SYNDROME | Abstract similar documents |
V. I. Podzolkov, T. V. Koroleva, A. Е. Bragina, M. G. Kudryavtseva, N. A. Druzhinina, M. V. Pisarev | ||
"... with MS was 7.3Ѓ}1.9%. The mean EEC level in group of MS patients (1.59Ѓ}0.05×107) was significantly lower ..." | ||
Vol 7, No 5 (2011) | ARRESTING OF COMPLICATED HYPERTENSIVE CRISES IN THE PHYSICIAN’S PRACTICE: URAPIDIL VALUE AND STUDY RESULTS | Abstract similar documents |
G. P. Arutyunov, L. G. Oganezova | ||
"... ) in the urapidil group reduced from 210.5±13.6 to 157.8±8.3 mmHg (p<0.05), and diastolic BP (DBP) - from 115.7±8 ..." | ||
Vol 17, No 1 (2021) | Comparative Assessment of the Clinical Course, Drug Therapy and Outcomes in Myocardial Infarction without or with Obstructive Coronary Artery Disease | Abstract similar documents |
O. A. Fomina, S. S. Yakushin | ||
"... into two groups: 103 patients (group 1; MINOCA) did not have obstructive involvement coronary arterial (CA ..." | ||
Vol 9, No 4 (2013) | COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE | Abstract similar documents |
L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky | ||
"... elective cardioversion was 21±2 and 30.5±4.5 days for dabigatran and warfarin groups, respectively (p<0.05 ..." | ||
Vol 8, No 3 (2012) | COMPARATIVE EFFECTIVENESS PIPOFEZINE, TIANEPTINE AND CHLORPROTHIXENE IN PATIENTS WITH ATTENTION DEFICIT DISORDER , AND HYPERTENSION: AN OPEN NON-RANDOMIZED STUDY | Abstract similar documents |
V. V. Glushchenko | ||
"... of neurophysiological parameters (increase in EEG frequencies index) in groups 1 and 2 (from 0.37±0.05 to 0.54±0 ..." | ||
Vol 18, No 4 (2022) | Refractory Arterial Hypertension: Features of Neurohormonal and Water-salt Imbalanceand Approaches to Antihypertensive Drug Therapy | Abstract similar documents |
O. B. Kuzmin, V. V. Zhezha | ||
"... from patients with resistant hypertension with the higher of sympathetic nervous system activity ..." | ||
Vol 9, No 6 (2013) | COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY | Abstract similar documents |
I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko | ||
"... increased by 18.2% (p<0.05). Group 2: the average CHF class decreased by 29.6% (p<0.01), EF increased by 18 ..." | ||
Vol 15, No 1 (2019) | How Does the Presence of Diabetes Affect the Course of Acute Coronary Syndrome in Elderly Patients in Actual Clinical Practice? | Abstract similar documents |
M. R. Atabegashvili, E. V. Konstantinova, M. D. Muksinova, A. E. Udovichenko, A. P. Nesterov, M. O. Zheltoukhova, L. S. kyzy Muradova, M. Y. Gilarov | ||
"... -vessel disease (15% vs 25.6%; p<0.05) between groups 3 and 4. Glomerular filtration rate (GFR) <60 ml/min ..." | ||
Vol 8, No 5 (2012) | POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY | Abstract similar documents |
R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov, Kh. M. Raubzhanov | ||
"... of patients in the group 2 was significantly older than this in patients of the group 1 (p<0.05). CTI, left ..." | ||
Vol 14, No 1 (2018) | THIRTY-YEAR CHANGES IN AVERAGE BLOOD LIPIDS LEVELS IN POPULATIONS OF THE RUSSIAN FEDERATION AND THE USA | Abstract PDF (Eng) similar documents |
S. A. Shalnova, V. G. Vilkov, V. A. Metelskaya, Yu. A. Balanova, A. V. Kapustina | ||
"... , as compared to the USA one, most age groups demonstrate a higher concentration of total cholesterol, i.e. p<0.05 ..." | ||
Vol 15, No 5 (2019) | Comparative Study of the Results of a Three-year Observation of Cardiologists and Surgeons in Patients with Peripheral Atherosclerosis | Abstract similar documents |
L. S. Barbarash, A. N. Sumin, Yu. D. Medvedeva, E. V. Korok | ||
"... . Material and methods. The first group included 131 patients with PA who sought medical attention ..." | ||
Vol 6, No 5 (2010) | EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY | Abstract similar documents |
O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva | ||
"... ) scheduled for laparoscopic cholecystectomy were examined. Patients were randomized into 2 groups. Patients ..." | ||
Vol 6, No 4 (2010) | HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD | Abstract PDF (Eng) similar documents |
A. A. Abdullaev, R. M. Gafurova, U. A. Islamova, I. A. Kadieva, R. G. Khabchabov | ||
"... .4 мs2, respectively. SDNN rose from 27.8±3.2 to 52.4±4.4 ms (p<0.05) in the second group, from 27.4±2 ..." | ||
Vol 17, No 4 (2021) | Arterial hypertension and antihypertensive therapy in older patients. The agreed opinion of experts from the Russian Association of Gerontologists and Geriatricians, the Antihypertensive League, the National Society for Preventive Cardiology | Abstract similar documents |
O. N. Tkacheva, Yu. V. Kotovskaya, N. K. Runikhina, E. V. Frolova, V. S. Ostapenko, N. V. Sharashkina, E. I. Baranova, S. V. Bulgakova, S. V. Villevalde, D. V. Duplyakov, A. N. Ilnitskiy, O. A. Kislyak, Zh. D. Kobalava, A. O. Konradi, S. V. Nedogoda, Ya. A. Orlova, N. V. Pogosova, K. I. Proshchaev, G. A. Chumakova | ||
"... in these groups of patients indicate an increase in morbidity and mortality with lower blood pressure ..." | ||
Vol 7, No 6 (2011) | MITRAL ANNULAR CALCIFICATION IN ELDERLY PATIENTS. CLINICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS | Abstract similar documents |
N. S. Chipigina, G. M. Urvacheva, N. A. Shostak, I. V. Zhitareva, I. Yu. Zhitomirskaya | ||
"... .410). The frequency of stroke in patients with and without MAC did not differ (p>0.05). In the group of patients ..." | ||
Vol 7, No 3 (2011) | COMPARATIVE ANALYSIS OF ARTERIAL HYPERTENSION TREATMENT IN MEN AND WOMEN BASED ON THE RESULTS OF ACCORD STUDY (ACRIDILOLE IN COMBINATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY OR TYPE 2 DIABETES) | Abstract similar documents |
S. A. Shalnova, S. Yu. Martsevich, A. D. Deev, Yu. V. Lukina, E. N. Hoseva | ||
"... times - in women (p<0.05) in group A, and in 2.7 and 3.3 times, respectively , — in the control group (p ..." | ||
Vol 9, No 2 (2013) | MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) | Abstract similar documents |
S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina | ||
"... in the main group compared to the control (p<0.05). Statins were constantly taken by 34% of patients ..." | ||
Vol 18, No 6 (2022) | Evaluation of Fibrosis Markers as a Potential Method for Diagnosing Non-Obstructive Coronary Artery Disease in Patients with Stable Coronary Artery Disease | Abstract similar documents |
N. N. Pakhtusov, A. O. Yusupova, K. A. Zhbanov, A. A. Shchedrygina, E. V. Privalova, Yu. N. Belenkov | ||
"... volunteers (p <0.001). There were no significant differences between the main and control groups (p>0.05 ..." | ||
Vol 18, No 5 (2022) | Pararenalfat Tissue: Rate of Pararenal Obesity and Relation with Anthropometric Indices of Obesity | Abstract similar documents |
V. I. Podzolkov, A. E. Bragina, K. K. Osadchiy, J. N. Rodionova, D. A. Bayutina | ||
"... was detected on a single slice at the level of the left renal vein. Results. 27% of the examined group had BMI ..." | ||
Vol 17, No 2 (2021) | Adherence to Medical Treatment in Elderly Patients with Coronary Artery Disease in the Settings of Primary Outpatient Care | Abstract PDF (Eng) similar documents |
S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, N. N. Shindryaeva, D. A. Klyuev, L. N. Stepanyan, A. M. Lutsenko, A. T. Tsai, A. A. Danilova | ||
"... patients. These groups were comparable in terms of sex (female 71.2 vs 68.0%; p>0.05) and age (median 73 ..." | ||
Vol 15, No 1 (2019) | Comparison between Bolus Intracoronary versus Bolus Intravenous Injection Regimens of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Anterior ST-Segment Elevation Myocardial Infarction | Abstract PDF (Eng) similar documents |
Mohamed Hassan Nab, Shaimaa Mostafa, Khaled Elrabat, Hamza Kabil, Neama Elmelegy | ||
"... into 2 groups (group A received bolus I/C eptifibatide and group B received it I/V) followed by 12-hour ..." | ||
Vol 9, No 1 (2013) | ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION | Abstract similar documents |
A. N. Zakirova, E. R. Abdukova, N. E. Zakirova | ||
"... in the study. All participants were divided into four groups according to the presence of AF and CHF class ..." | ||
Vol 8, No 2 (2012) | QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL | Abstract similar documents |
E. L. Artanova, L. E. Kon'shina, I. M. Sokolov, Y. G. Shvarts | ||
"... .0) points (p<0.05). At the same period opposite dynamics was observed in patients of the control group after ..." | ||
Vol 17, No 4 (2021) | E-cigarette Smoking (Vaping) and Markers of Vascular Wall Damage in Young Subjects without Cardiovascular Disease | Abstract PDF (Eng) similar documents |
V. I. Podzolkov, A. E. Bragina, N. A. Druzhinina, L. N. Mohammadi | ||
"... inhaled nicotine dose. In the group of vapers, CRP was associated with smoking experience (rs=0.338, p<0.05 ..." | ||
Vol 18, No 5 (2022) | The Role of Structured Telephone Support in the Development of Self-care in Comorbid Patients with Chronic Heart Failure | Abstract PDF (Eng) similar documents |
E. D. Kartamysheva, Yu. M. Lopatin | ||
"... in the telephone support group (p>0.05).However, there were no statistically significant differences in the intake ..." | ||
Vol 17, No 5 (2021) | A Randomized Open Clinical Study of the Atherosclerosis Treatment Information Video Effect on Adherence to Long-Term Therapy in Patients with Cardiovascular Diseases | Abstract PDF (Eng) similar documents |
Yu. V. Bulaeva, E. A. Naumova, O. N. Semenova, T. V. Kanaeva, K. A. Popov, А. R. Tyapayeva | ||
"... in the intervention group continued taking statins versus 29 (43%) respondents in the control group (p<0.05), 3 months ..." | ||
Vol 8, No 3 (2012) | EFFECT OF THE ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE ON THE OXIDATIVE MODIFICATION OF SERUM PROTEINS IN PATIENTS WITH ISCHEMIC STROKE | Abstract similar documents |
T. N. Khaybullin, E. Yu. Kravtsova, G. A. Martynova | ||
"... ) and 20 healthy subjects matched for age and sex (control group) were included in the study. IS patients ..." | ||
Vol 18, No 1 (2022) | Arterial Stiffness Parameters and Subendocardial Viability Ratio in Patients with Arterial Hypertension Affected by Subclinical and Clinical Atherosclerosis | Abstract similar documents |
V. E. Gumerova, V. V. Gomonova, S. A. Sayganov | ||
"... .3±1.8, 11.5±1.7 respectively; p<0.05) compared with control group (SBP 116.3±7.3; SBPao 108.9±6.4, PP ..." | ||
Vol 7, No 2 (2011) | A COMPARATIVE STUDY OF THE EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN MONOTHERAPY OR IN COMBINATION WITH S-AMLODIPINE AND INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 DEGREES. RESULTS OF THE CLINICAL RANDOMIZED CROSSOVER STUDY | Abstract similar documents |
S. Yu. Martsevich, S. N. Tolpygina, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, I. V. Vashurina | ||
"... .5±8.6 beats/min in group 2 (p<0.05 for both groups). Significant dynamics of PQ interval were ..." | ||
Vol 18, No 6 (2022) | The Effect of Angiotensin Receptor and Neprilysin Inhibitors on Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction and Functional Mitral Regurgitation | Abstract similar documents |
A. S. Ryazanov, E. V. Shikh, O. V. Kechina, M. V. Makarovskaya, A. A. Kudryavtsev | ||
"... class III to II increased in the sacubitril/valsartan group (p<0.05). Also, in this group, the effective ..." | ||
Vol 6, No 1 (2010) | EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS | Abstract PDF (Eng) similar documents |
D. M. Aronov, V. B. Krasnitskij, M. G. Bubnova | ||
"... % (p<0.001) in the main group. Decrease in total cholesterol (TC) by -3.6% (p<0.05) and increase ..." | ||
Vol 18, No 2 (2022) | Comparative Efficacy of Single Pill Combinations of Azilsartan Medoxomil/Chlorthalidone and Losartan/Hydrochlorothiazide in Patients with Hypertension and Heart Failure with Preserved Ejection Fraction | Abstract similar documents |
Zh. D. Kobalava, A. F. Safarova, Kh. M. Gudieva, M. A. Markova, A. E. Petrosyan | ||
"... in the second group reached the target clinical BP (р<0,05). Average daily BP <130/ <80 mm Hg was reached by 82 ..." | ||
Vol 18, No 3 (2022) | The Effect of Enhanced External Counterpulsation on the Vascular State, Indicators of Glycemic Control and Quality of Life in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus | Abstract PDF (Eng) similar documents |
O. A. Slepova, A. S. Lishuta, E. Yu. Vasiltsova, E. V. Privalova, Yu. N. Belenkov | ||
"... , patients were randomized into 2 groups: EECP (n=15) and a comparison group (n=15). All patients (n=30 ..." | ||
Vol 2, No 2 (2006) | COMPARISON OF EFFECTS OF ENALAPRIL AND UNCONTROLLED ANTIHYPERTENSIVE THERAPY ON INSULIN RESISTANCE, ENDOTHELIUM FUNCTION, MARKERS OF INFLAMMATION AND PLATELET ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME | Abstract similar documents |
M. N. Mamedov, T. V. Ektova, O. A. Litinskaya, T. Sh. Dzhakhangirov, O. V. Kosmatova | ||
"... in the 1st group increased by 14% before glucose load, and by 25% (p<0,05) 2 hours after peroral glucose ..." | ||
Vol 16, No 3 (2020) | Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina | Abstract similar documents |
S. A. Boldueva, I. A. Leonova, O. V. Zakharova | ||
"... into the study and randomized into 3 groups. Patients of the first group (control; n=30) received standard ..." | ||
Vol 18, No 4 (2022) | Left Atrium Involvement in Lymphoma Patients: Single Center Observational Study | Abstract similar documents |
E. Yu. Salakheeva, I. Ya. Sokolova, O. V. Lyapidevskaya, K. A. Zhbanov, S. A. Tsatsurova, N. I. Kanevskiy, V. O. Stebakova, E. V. Privalova, I. S. Ilgisonis, Yu. N. Belenkov, A. A. Shchendrygina | ||
"... no prior polychemotherapy. The comparison group included persons without lymphoma [n=18; 50% men; median ..." | ||
Vol 7, No 5 (2011) | AMLODIPINE IN CORRECTION OF HIGH RISK ARTERIAL HYPERTENSION: FOCUS ON MECHANISMS OF INFLAMMATION | Abstract similar documents |
A. A. Tarasov, S. I. Davydov, T. A. Bezborodova, M. A. Gordeeva, A. R. Babaeva | ||
"... by 17.1±5.8/11.4±4.0 mmHg (p<0.05) was revealed in the main group and by 13.6±4.7/8.9±5.3 mm Hg ..." | ||
Vol 2, No 2 (2006) | THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL | Abstract similar documents |
Y. R. Kasherininov, E. K. Shavarova, A. A. Shavarov, N. V. Vachrameeva, A. N. Krutikov, E. V. Smirnova, A. O. Коnrady, E. V. Shlyakhto | ||
"... was equally achieved in both treatment arms. The fasting glucose level increased in the atenolol group from 4 ..." | ||
Vol 14, No 1 (2018) | NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME | Abstract similar documents |
K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev | ||
"... patients that are resistant to clopidogrel (PRU>208) and in patients with a normal response to clopidogrel ..." | ||
Vol 10, No 2 (2014) | PRIMARY PREVENTION OF MYOCARDIAL INFARCTION IN MIDDLE-AGED MALES (15-YEAR FOLLOW-UP): CLINICAL AND ECONOMIC ASPECTS OF THE PROBLEM | Abstract PDF (Eng) similar documents |
A. M. Kalinina, A. V. Kontsevaya | ||
"... to the second group, fatal MI incidence rate was 42.4% lower, p<0.05. Mortality rate in new cases of MI was 35 ..." | ||
Vol 11, No 2 (2015) | DIAGNOSTIC VALUE OF GALECTIN-3 LEVEL IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES | Abstract similar documents |
A. A. Snetkova, N. Yu. Timofeeva, V. S. Zadionchenko | ||
"... .53; p<0.05), while in the group with PEF, the correlation was not significant (p=0.225). In the group ..." | ||
Vol 14, No 2 (2018) | MONITORING OF THE EFFICACY AND SAFETY OF HIGH-DOSE ATORVASTATIN IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION | Abstract similar documents |
L. I. Salyamova, S. S. Fadeeva, A. V. Golubeva, Yu. A. Tomashevskaya, V. E. Oleynikov | ||
"... of BNP was also found in Group 1 by 60% (p=0.005), and in Group 2 – by 33.8% (p<0.001). The levels of CPK ..." | ||
Vol 18, No 2 (2022) | The Influence of Multivessel Bypass Surgery on the Onset of Atrial Fibrillation in Elderly Patients | Abstract similar documents |
O. A. Rubanenko, A. O. Rubanenko | ||
"... . Patients were divided into 4 groups: 1 group – with single-vessel bypass, 2 group – with 2-vessels, 3 group ..." | ||
Vol 4, No 4 (2008) | EFFICACY AND SAFETY OF GINKGO BILOBA IN ELDERLY PATIENTS WITH CONTROLLED ARTERIAL HYPERTENSION AND CIRCULATORY ENCEPHALOPATHY | Abstract similar documents |
V. V. Jakusevich, N. V. Semenova, I. A. Tihomirova, A. V. Muravyov, S. V. Lychenko | ||
"... randomized (3:1) on Memoplant (240 mg/daily) treatment group and control group. Duration of observation ..." | ||
Vol 3, No 5 (2007) | RENAL HEMODYNAMICS AND GLOMERULAR FILTRATION RATE IN MEN AND WOMEN WITH ARTERIAL HYPERTENSION AT THE AGE OF 40-60 YEARS | Abstract similar documents |
I. G. Fomina, A. E. Bragina, N. E. Gaydamakina, J. N. Salimzhanova | ||
"... not differ in control group. Positive correlation r=0,61; p<0,05) between GGFR and a tobacco smoking ..." | ||
Vol 13, No 1 (2017) | CHANGE OF ARRHYTHMIC EVENTS IN ACUTE MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION AFTER PHARMACOINVASIVE REVASCULARIZATION | Abstract similar documents |
V. E. Oleynikov, E. A. Shigotarova, A. V. Kulyutsin, E. V. Dushina, J. A. Guskova | ||
"... (–) group, in the RT(+) group after PCI VT were recorded more frequently (44% vs 63.6%, respectively; p<0.05 ..." | ||
Vol 12, No 6 (2016) | BURNOUT SYNDROME IN PATIENTS WITH WORKPLACE HYPERTENSION | Abstract similar documents |
Yu. P. Zinchenko, E. I. Pervichko, O. D. Ostroumova | ||
"... }3.67 points vs 24.6Ѓ}4.3 and 20.1Ѓ}5.7 points in group 2, and group of healthy, respectively; p<0.05 ..." | ||
Vol 3, No 2 (2007) | CARDIAC RUPTURE IN MYOCARDIAL INFARCTION: INCIDENCE AND PREDISPOSING FACTORS (15 YEAR FOLLOW-UP) | Abstract similar documents |
V. A. Shulman, S. E. Golovenkin, V. V. Radionov, T. M. Parfenova, G. V. Matyushin | ||
"... patients (3,4%) of group II (1993) and in 10 of 531 patients (1,9%) of group 3 (2003), (p1,3 <0,05 ..." | ||
1 - 100 of 954 Items | 1 2 3 4 5 6 7 8 9 10 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)